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1. Specific Aims 
The goals of this proposal are three-fold. First, the study will address the hypothesis that 
equations can be derived from basic fluid mechanic principles to quantify regurgitant volume using 
quantities that can be directly measured by Doppler. Second, these basic physical principles can 
be used to interpret color flow mapping variability related to regurgitant jet behavior in the presence 
of solid structures or interrupting flows. Third, additional variability inherent to measurement 
technique (i.e. instrument settings) will be addressed. 
To achieve these objectives, the following specific aims are proposed: 1) to derive  
equations from the principles of turbulent jet flow and conservation of mass which provide orifice 
flow rate, and therefore regurgitant volume, as a function of Doppler measurable quantities; 2) in 
in vitro models, to test the accuracy of the equations in predicting actual regurgitant volume; 3) to 
define in an in vitro model, the relationship between regurgitant flow, and spatial characteristics of 
the color flow jet, namely, jet length, width, area, and volume; 4) in in vitro models, to address 
the variability in these relationships due to machine settings, driving pressure, and physiologically 
observed jet flow phenomena, namely, the Coanda effect, impingement, counterflow, and coflow; 
and 5) to investigate the applicability of the quantitation techniques to various designs of heart 
valve prostheses. 
These comprehensive studies are performed in vitro in order to allow precise and 
independent control of all variables. In vivo studies, while providing realistic environments, do 
not generally allow independent control of variables such as required for such fundamental studies. 
Careful design of flow models provides semi-realistic environments, while allowing dependent 
control. 
2. Studies and Results 
A. EI-1-LCTS OF CONFINED AND IMPINGING REGURGITANT JETS 
Methods have recently been developed for noninvasive quantification of valvular 
regurgitant flow rate (Q op) based on conservation of momentum within free turbulent jets 
and the resulting decay of peak centerline velocities (li mp) distal to the orifice. Before 
clinical implementation, however, the method must account for realistic environments in 
which jets are limited axially (impinging on distal walls), confined laterally or both, causing 
more rapid velocity decay. We proposed that accurate results could be achieved for such 
jets using a technique based on the continuity principle coupled with a dimensional analysis 
involving factory affecting U mp : receiving chamber diameter (D i) orifice-to-end wall 
distance (H), distance from the orifice, peak orifice velocity (U 09) and orifice diameter 
(D0). The purpose of this study was to validate this method in vitro, over a wide range of 
heart rates (HR), U op, and H. Physiologic pulsatile flows were pumped through circular 
orifices (D0=2,4 mm) at 70 - 150 beats/min in two receiving chambers (D c=51, 88 mm); at 
each HR, Uop was varied from 2 - 5 m/s. H varied from 30 - 93 mm. U m, was measured 
by pulsed Doppler ultrasound over multiple beats and Q op calculated. Predicted Qv agreed 
well with actual values by electromagnetic flow probe, independent of HR. For example, 
for Dc=51 mm, H= 66 mm, the regression for Qop was y=0.97x-0.21 (r=0.99). For 
Dc=51 mm, H=30 mm, the regression was y= 1.01x+0.13 (r=0.99). For a wide range of 
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geometries confining jets axially and laterally, Q op can be accurately predicted in vitro from 
velocities that can be directly measured by conventional Doppler. 
12/31/93 
B . INSTRUMENTATION FACTORS IN ASSESSING REGURGITANT JET SIZE 
Color Doppler (CD) jet flow area (CDA) continues to be used as the primary noninvasive 
marker of the severity of valvular regurgitation (VR) and the transesophageal approach 
(TEE) has aided visualization of CDA in prosthetic valves. It has been shown that CDA 
varies significantly between transthoracic and TEE views within a given instrument. In 
order to define useful thresholds of severity of VR, it is critical to examine the variability 
between different instruments and between instrument settings for the same flow. This 
study therefore addressed the effect of instrument settings and intermachine variability in a 
comprehensive manner using six commonly used TEE instruments. Commercially 
available CD instruments by Acuson, Aloka, ATL, HP, Toshiba and VingMed with 5 MHz 
transesophageal probes were used to image pulsatile jet flow through a 5 mm orifice using 
a blood analog fluid. For all six machines studied, a reduction in Nyquist Limit (0.46 -
0.32 m/s) resulted in an increase in CDA (8.82-18.10 cm 2) (p=0.001). Nyquist limit 
should not in principle affect CDA, and these changes are explained by changes in wall 
filter. With other settings constant, increasing sector angle (45°-90°) produced larger jets 
(13.23 - 18.44 cm2) due to lateral resolutions effects (p0.01). Virtually identical setting 
combinations showed intermachine differences as high as 57%. Instrument settings cause 
significant variations in CDA for constant flow conditions and so must be annotated and 
recorded. Limited setting choices and arbitrary annotation prohibits extrapolation of 
assessment techniques between instruments. 
C. PROSTHETIC VALVE STUDIES 
A theoretical treatment using turbulent jet theory has yielded a new equation for predicting 
regurgitant flow through bileaflet heart valve prostheses, the most commonly implanted 
mechanical valve design. Previously reported techniques assuming an axisymmetric jet are 
not applicable to the slot-like orifices presented in these valves. The equations were 
therefore rederived in the context of the prosthetic valve geometry. The purpose of this 
study was to develop such a method and demonstrate its applicability in principle by using 
in vitro models. The method was validated under both steady and pulsatile flow 
conditions. Having derived a method geometrically specific to the orifices presented in 
bileaflet mechanical heart valves. It should be applicable from patient to patient due to the 
rigid nature of the valve. These idealized in vitro studies, along with the accompanying 
theoretical derivation, will guide implementation in the clinical setting. 
D. COMPUTATIONAL STUDIES 
Recent computational studies have shown that the proximal isovelocity surface area (PISA) 
method can quantify valvular regurgitation. The purpose of this study was to determine 
whether it could be applied accurately in the presence of ventricular outflow, which can 
distort the PISA field. Finite difference solution of the Navier-Stokes equations was 
therefore performed in an anatomically correct 3-dimensional ventricular model. Flow was 
driven through 4-6 mm diameter regurgitant orifices by a 100 mmHg pressure gradient. 
Each orifice size was located centrally, or near the outflow tract or posterior wall. 
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Regurgitant flow rates (Q) ranged from 41 to 101 ml/s. For each aliasing velocity (V) and 
PISA radius (R) along the centerline of the orifice, the flow rate as calculated by 
Qc=27tR2V. To account for underestimation near the orifice and overestimation far from it 
(finite chamber and outflow effects), a polynomial was fitted to plots of Qc vs R, and Qc at 
the point of inflection taken as the best estimate of actual Q (least distortion). Qc at the 
point of inflection agreed well with actual values (mean error = 4.3 ml/s, or 6.1%), 
successfully accounting for potential overestimation, particularly nearest the outflow. This 
computational study confirms that ventricular outflow can distort adjacent PISAs, but that 
flow rate can still be calculated accurately by analysis of the proximal flow field in a way 
that could potentially be automated. 
Systolic pulmonary venous (PV) flow is primarily determined by atrial pressure events. As 
the atrium relaxes, atrial pressure decreases and creates a favorable gradient for forward 
systolic flow into the atrium. However, the additional volume of regurgitation causes atrial 
pressure to increase rapidly and creates a pressure gradient favoring flow out of the atrium 
(PV flow reversal). Since the rise in pressure due to additional volume is determined by 
atrial compliance, we tested the hypothesis that the presence and magnitude of flow reversal 
is not only a function of regurgitant volume but depends on atrial compliance as well. A 
mathematical model of an atrium with varying compliance and PVs was developed. The 
atrial pressure-volume (compliance) relationship was modeled as an exponential function: 
initially rapidly increasing compliance (atrial relaxation) which then decreased as atrial 
volume increased. A simplification of the Navier-Stokes fluid flow equations was used to 
solve for PV velocities that result from the developed pressure gradient. Using an initial 
atrial volume of 40 cc (normal), the modeling was performed over a range of initial atrial 
compliances (C = 3-10 cc/mrnHg),with and without the addition of a regurgitant jet. The 
model realistically simulated the systolic PV waveform in magnitude and morphology. As 
the volume of regurgitation increased, peak flow velocity decreased, and eventually late 
systolic flowreversal occurred. However, the presence andmagnitude of flow reversal was 
determined by atrial compliance. As the initial atrial compliance decreased, the magnitude 
of flow reversal increased,because higher atrial pressures were developed andpromoted 
flow out of the atrium into the PVs. PV flow reversal depends on atrial compliance as well 
as regurgitant volume. As initial atrial compliance decreases (stiffer atria), the likelihood of 
flow reversal increases. As a result, flow reversal is more likely in acute compared to 
chronic regurgitation because the atrium is less compliant. 
E. EFFECT OF VALVULAR MOTION ON QUANTIFICATION OF 
REGURGITATION 
This study addressed the hypothesis that motion of the surface containing a regurgitant 
orifice relative to the Doppler ultrasound transducer can cause differences between actual 
flow rate and calculations based on the proximal flow convergence technique. In vitro 
studies quantitating regurgitant flow rate by proximal flow convergence have been limited 
to stationary orifices. Clinically, however, valve leaflets generally move relative to the 
ultrasound transducer during the cardiac cycle, and can move at velocities important relative 
to the measured color aliasing velocities. The transducer therefore senses the vector sum of 
actual flow velocity toward the orifice and orifice velocity relative to the transducer. This 
can cause potential over- or underestimation of true flow rate depending on the direction of 
surface motion. The hypothesis was explored computationally and tested by pumping fluid 
at a constant flow rate through an orifice in a plate moving at 0-8 cm/s (velocities 
12/31/93 
(Form Page 6) Page 	 (Use continuation pages if necessary) PHS 259C (Rev. 9/91) 
GR NUMBER 
PROGRESS _PORT SUMMARY 
HL 45485-04 
PRINCIPAL INVESTIGATOR OR PROGRAM DIRECTOR 
Alit P. Yoganathan 




Georgia Institute of Technology  
TITLE OF PROJECT (Repeat title shown in Item f on first page) 
Quantitation of Valvular Regurgitation: An In Vitro Study  
(SEE INSTRUCTIONS) 
comparable to those described clinically for mitral and tricuspid annular motion toward an 
apical transducer). 
Surface motion in the same direction as flow caused overestimation of the aliasing radius 
and calculated flow rate. Surface motion opposite to the direction of flow (typical for mitral 
and tricuspid regurgitation viewed from the apex or esophagus) caused underestimation of 
actual flow rate; the underestimation was greater for lower aliasing velocities (36 ± 11% for 
10 cm/s versus 23 ± 6% for 20 cm/s). Correcting for surface motion provided excellent 
agreement with actual values (y = 0.97x +0.10, r = 0.99, SEE = 0.17 limin). Physiologic 
motion of the surface containing a regurgitant orifice can cause substantial differences 
between actual flow rate and that calculated by the proximal flow convergence technique. 
Low aliasing velocities used to optimize that technique can magnify this effect. Such errors 
can be minimized by using higher aliasing velocities (compatible with the need to measure 
the aliasing radius) or eliminated by correcting for surface velocity determined by an M-




The results of our studies of the past year are providing valuable insight to cardiologists 
and cardiac surgeons in their efforts to non-invasively quantify valvular regurgitation using 
echo-Doppler techniques. 
The most significant achievements during the year were: 
(i) Application of fundamental engineering (fluid mechanic) principals to quantify 
confined and impinging valvular regurgitant jets. 
(ii) Demonstrating the effects of instrument setting on assessing regurgitant jet area 
using transesophageal color Doppler flow mapping. 
(iii) The fact that valvular motion needs to be considered when using the PISA method 
for quantifying regurgitant volume. 
4. 	Plans 
No changes to plans originally proposed. 
(i) Continue pulsatile flow studies on central and wall jets in counter and co-flowing 
environments. 
(ii) Continue pulsatile flow studies to test the validity of the proximal flow convergence 
technique to quantitate regurgitant volume. 
(iii) Conduct pulsatile flow studies on prosthetic heart valves, to study the applicability 
of the distal jet and proximal flow convergence techniques, to quantitate prosthetic 
valve regurgitation. 
(iv) Write journal articles based on the results of the studies conducted during the 
second and third years of the project. 
PHS 259C (Rev 9191) 
	
(Form Page 6) Page 	 (Use continuation pages if necessary) 
GFL NUMBER 
PROGRESS REPORT SUMMARY 
HI. 45485-04 
PERIOD COVERED BY THIS REPORT PRINCIPAL INVESTIGATOR OR PROGRAM DIRECTOR 
Aj it P. Yoganathan 
APPLICANT ORGANIZATION 




12 /3 1/ 9 3 
TITLE OF PROJECT (Repeat title shown in item 1 on first page) 
Quantitation of Valvular Regurgitation: An In Vitro Study 
(SEE INSTRUCTIONS) 
S . 	Human Subjects 
N/A 




1. Cape, E. G., Levine, R. A., and Yoganathan, A. P., "Increased Heart Can Cause 
Underestimation of Regurgitant Jet Size by Doppler Color Flow Mapping," 
Journal of the American College of Cardiology, vol. 21, pp. 1029-
1037, 1993. 
2. Cape, E. G., Nanda, N. C., and Yoganathan, A. P., "Quantification of 
Regurgitant Flow Through Bileaflet Heart Valve Prostheses: Theoretical and In 
Vitro Studies," Ultrasound in Medicine and Biology, vol. 19, pp. 461-
468, 1993. 
3. Cape, E. G., Kim, Y-H., Muralidharan, E., Heinrich, R. S., Grimes, R. Y., 
Levine, R. A., and Yoganathan, A. P., "Cardiac Motion Can Alter Proximal 
Isovelocity Surface Area Calculations of Regurgitant Flow," Journal of the 
American College of Cardiology (In Press). 
4. Walker, P. G., Kim, Y-H., Muralidharan, E., and Yoganathan, A. P., 
"Assessment of the Accuracy of Color Doppler Flow Mapping by Digital Image 
Analysis," Echocardiography (In Press). 
5. Grimes, R. Y., Hopmeyer, J., Levine, R. A., and Yoganathan, A. P., "Centerline 
Decoy in Counterflowing Jets: Implications for Quantification of Mitral and 
Tricuspid Regurgitation Using Jet Centerline Velocities," Circulation 
(submitted). 
6. Burleson, A., Fontaine, A., Levine, R. A., and Yoganathan, A. P., "A Model 
Based on Dimensional Analysis for Noninvasive Quantification of Valvular 
Regurgitation Under Confined and Impinging Conditions: In Vitro Pulsatile Flow 
Validation," Circulation (submitted). 
B . 	Abstracts & Conference Presentations 
1. Mele, D. Vandervort, P. M., Cape, E. G., Yoganathan, A. P., Thomas, J. D., 
Weyman, A. E., and Levine, R. A., "Doppler Echocardiographic Quantification of 
Tricuspid Regurgitation by the Momentum Method: In Vivo Validation," 65th 
Annual Scientific Session - American Heart Association, Circulation, 86, pp. I-
253, 1992. 
2. Grimes, R. Y., Walker, P. G., Nyarko, S. J., and Yoganathan, A. P., "Atrial 
Inflow Can Alter Color Doppler Regurgitant Jet Area: In Vitro Studies," 65th 
Annual Scientific Session - American Heart Association, Circulation, 86, pp. I-
318, 1992. 
3. Cape, E. G., Levine, R. A., Muralidharan, E., Heinrich, R., and Yoganathan, A. 
PH5 2590 (Rev. 9/91) (Form Page 6) Page _ 	 (Use continuation pages if necessary) 
F 
GRA 44UMBER 
PROGRESS puiPORT SUMMARY 
EL 45485-04 
PERIOD COVERED BY THIS REPORT 
APPLICANT ORGANIZATION 
Georgia Institute of Technology 	 01/01/93 
TITLE OF PROJECT °Waal title shown In nom Ion 'Inn MOO 
Quantitation of Valvular Regurgitation: An In Vitro Study  
SEE INSTRUCTIONS) 
P. "Increased Heartrate Can Cause Underestimation of Regurgitant Flow by 
Proximal Isovelocity Surface Area," 65th Annual Scientific Session - American 
Heart Association, Circulation, 86, pp. 1-804, 1992. 
4. Cape, E. G., Yoganathan, A. P. Muralidharan, E., Heinrich, R., and Levine, R. 
A., "Cardiac Motion Can Alter Proximal Isovelocity Surface Area Calculations of 
Regurgitant Flow, " 65th Annual Scientific Session - American Heart Association, 
Circulation, 86, pp. 1-258, 1992 
5. Fan, P-H., Anayitos, A., Cape, E. G., Yoganathan, A. P., and Nanda, N. C., 
"Intermachine Variability in Transesophegeal Color Doppler Images of Pulsatile 
Jets," 65th Annual Scientific Session - American Heart Association, Circulation, 
86, pp. 1-318, 1992. 
6. Grimes, R. Y., Walker, P. G., Nyarko, S. J., Levine, R. A., and Yoganathan, A. 
P., "Dynamics and Quantification of Counterflowing Jets: Application to Mitral 
and Tricuspid Regurgitant Jets Opposed by Atrial Inflow," The Winter Annual 
Meeting of the American Society of Mechanical Engineers, Anaheim, CA, 
November 1992. 
7. Cape, E. G, Muralidharan, E., Heinrich, R. S., Levine, R. A., and Yoganathan, 
A. P., "The Effect of Surface Motion on Proximal Isovelocity Surface Area (PISA) 
Calculations of Flow by Color Doppler Flow Mapping," The Winter Annual 
Meeting of the American Society of Mechanical Engineers, Anaheim, CA, 
November 1992, 1992 Advances in Bioengineering, pp. 435-438. 
8. Grimes, R. Y., Walker, P. G., Hopmeyer, J., Yoganathan, A. P. and Levine, R. 
A., "Counterflowing Wall Jets are Relatively Longer than Central Jets-Implications 
for Regurgitant Jets Opposed by Atrial Inflow: In Vitro Studies," JACC, vol. 21, 
pp. 240A, 1993. 
9. Grimes, R. Y., Cape, E. G., Walker, P. G., Yoganathan, A. P., and Levine, R. 
A., "Crossflow Augments Color Doppler Jet Area," JACC, vol. 21, pp. 367A, 
1993. 
10. Burleson, A. C., Mele, D., Yoganathan, A. P., Levine, R. A. "Noninvasive 
Quantification of Regurgitant Orifice Diameter Based on Laminar 
, 
	Length: In 
Vitro Laser and Ultrasound Doppler Studies," JACC, vol. 21, pp. 486A, 1993. 
11. Grimes, R. Y., Levine, R. A., Yoganathan, A. P., "A New Method for 
Quantifying Mitral & Tricuspid Regurgitant Jets Opposed by Atrial Inflow," 
JASE, vol. 6, pp. S27, 1993. 
12. Schwammenthal, E., Cape, E. G., Weyman, A. E., Yoganathan, A. P., Levine, 
R. A., "Impact of Mitral Orifice Motion in the Calculation of Regurgitant Flow 
Rates by the Proximal Flow Convergence Method: Clinical Data," JASE, vol 6, 
pp. S25, 1993. 
13. Grimes, R. Y., Yang, S., Pulido, G., Levine, R. A., Yoganathan, A. P., "The 
Combined Effect of Atrial Walls and Inflow on Jet Dimensions," ASME BED, 
vol. 24, pp. 477-480, 1993. 
14. Burleson, A. C., Levine, R. A., Yoganathan, A. P., "Quantification of Valvular 
Regurgitation: An In Vitro Study of Confined Impinging Jets," ASME BED vol. 
24, pp. 485-488, 1993. 
THROUGH 
12/31/93 
PRINCIPAL INVESTIGATOR OR PROGRAM DIRECTOR 
Alit P. Yoganathan 
8 . 	Inventions and Patents 
None 
PHS 2590 (Rev. Ni) 	 (Form Pap 6) Page 	 (Use continuation pages fl  nezaaaaty) 
PROGRESS REPORT (f onne! and Study Subjects) FOR/ NUMBER HL 45485-04 
All Personnel for the Current Budget Period 
and Any Planned Changes In Personnel for the Next Budget Period 
Use two sections. In the first section list All Current Personnel. In the second section list Planned Personnel Changes. 
Name Degree(s) SSN Role on Project 
(e.g., P1, Res. Assoc.) 





A. P. Yoganathan Ph.D. 569-27-7B75 PI 12/6/51 25 
R. A. Levine M.D. 060-46-5316 Consultant 1/29/53 7.5 
A. Burleson B.S. 255-67-3026 Grad Student 1/26/66 50 
R. Grimes M.D. 256-02-7222 Grad Student 12/27/62 100 
R. Heinrich B.S. 141-48-6193 Grad Student 1/17/69 50 
J. Hopmeyer 	_ B.S. 033-72-5382 Grad Student 3/11/69 100 
F. Guenet B.S. 252-81-8719 Grad Student 10/7/68 25 
P. G. Walker Ph.D. 252-751-226 Post Doc Fel 10/27/61 50 
A. Fontaine Ph.D. 039-34-5580 Post Doc Fel 11/19/62 75 
Y. H. Kim Ph.D. 484-11-4483 Post Doc Fel 1/19/60 25 
B. Chand 382-56-7920 Secretary 11/23/52 10 
PLANNED PERSONNEL CHANGES 
A. Burleson & F. Guenet, have completed their graduate studies at Georgia Ted. 
No other changes are 
currently planned. 




 Asian or Pacific 
islander 
Black, not of 
Hispanic Origin Hispanic 









PHS 2590 (Rev. 9 91) 
	 (Form Page 7) Page 	 (Use continuation page if necessary) 
G T NUMBER 
CHECKLIST 	
EL 45485-04_  
Check the appropriate boxes and provide the information requested. Make this page the last page  of the signed original of the applicatior 
1. ASSURANCESICERTFICATIONS 
The following assurances/certifications are made by checking the appropriate boxes and verified by the signature of the OFFICIAL SIGN-
ING FOR APPLICANT ORGANIZATION on the FACE PAGE of the application. Descriptions of individual assuranceslcertifications begin or 
page 9 of Specific Instructions. 
a Human Subjects (Complete Item 7 on the Face Page) 
❑ Full IRE Review 	❑ Expedited Review 
Use of Human Subjects ❑ Change 	D11 No Change Since Previous Submission  
b. Vertebrate Animals (Complete Item 8 on the Face Page) 
Use of Vertebrate Animals ❑ Change [X No Change Since Previous Submission 
c. Inventions and Patents (Complete Item 11 on the Face Page)  
d. Debarment and Suspension j No 	❑ Yes (Attach explanation)  
e. Lobbying 
With Federal appropriated funds 	 [Id No 
With other than Federal appropriated funds 	13 No 	❑ Yes 
(If "yes", see page 13, and attach Standard Form LL_, "Disclosure of Lobbying Activities," to the application behind the Checklist.) 
f. Delinquent Federal Debt 	PS] No 1=1 Yes (Attach explanation) 
g. Misconduct in Science (Form PHS 6315) 	❑ Filed 	Not Filed 
	
if filed, date of Initial Assurance or latest Annual Report  
h. Civil Rights i. Handicapped Individuals j. Sex Discrimination k. Age Discrimination 
Form HHS 441 Form HHS 641 Form HHS 8394 Form HHS 680 
11 Filed EN Filed GI Filed LI Filed 
❑ Not Filed ❑ Not Filed ❑ Not Filed ❑ Not Filed 
2. PROGRAM INCOME (See instructions, Page 16) 
All applications must indicate (Yes or No) whether program income is anticipated during the period(s) for which grant support is 
requested. EN No 	❑ Yes. If "Yes" use the format below to reflect the amount and source(s) of anticipated program income. 
Budget Period 	 Anticipated Amount 	 Source(s) 
3. INDIRECT COST 
indicate the applicant organization's most recent indirect cost rate established with the appropriate DHHS Regional Office, or, in the case 
of forprof it organizations, the rate established with the appropriate PHS Agency Cost Advisory Office. Indirect costs will not be paid on 
foreign grants, construction grants, grants to Federal organizations and grants to individuals, and usually not on conference grants. Follow 
any additional instructions provided for Research Career Development Awards, Institutional National Research Service Awards, and 
specialized grant applications. 
❑ DHHS Agreement Dated: 	  ❑ No Indirect Costs Requested 
El No DHHS Agreement, but rates established with  Office of Naval Research 	Date  29 lune 93  
CALCULATION* 
Enter proposed budget period: 
-95051 37 x Rate applied 	 % = Indirect costs S 35169  Amount of base S  
Add to total direct costs from form page 2 and enter new total on Face Page, item 10b 
'Check appropriate box(es): 
❑ Salary and wage base 	 DI Modified total direct costs base 	 ❑ Other base (Attach explanation) 
❑ Off•site, other special rate, or more than one rate involved (Attach explanation) 
PHS 2590 (Rev. 9/91) 
	
(Form Page 8) Page 
